Literature DB >> 35411091

Is representation enough or should we be targeting equitable inclusion?

Scarlett Lin Gomez1,2, Chiaojung Jillian Tsai3.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35411091     DOI: 10.1038/s41571-022-00635-z

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   65.011


× No keyword cloud information.
  3 in total

1.  The Problem of Hispanic/Latinx Under-Representation in Cancer Clinical Trials.

Authors:  Manuel R Espinoza-Gutarra; Narjust Duma; Paula Aristizabal; Barbara Segarra-Vazquez; Hala Borno; Chanita Hughes Halbert; Melissa A Simon; Ana I Velazquez
Journal:  JCO Oncol Pract       Date:  2022-05

2.  Measuring the Trustworthiness of Health Care Organizations and Systems.

Authors:  Andrew Anderson; Derek M Griffith
Journal:  Milbank Q       Date:  2022-03-15       Impact factor: 6.237

3.  Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology.

Authors:  Jeunice Owens-Walton; Cheyenne Williams; Alexis Rompré-Brodeur; Peter A Pinto; Mark W Ball
Journal:  J Clin Oncol       Date:  2022-02-23       Impact factor: 50.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.